Spectrum of Activity

by

Voriconazole is a broad-spectrum antifungal medication used primarily to treat serious fungal infections. It belongs to the class of triazole antifungals and is effective against a variety of fungal pathogens. Understanding its spectrum, dosing, and potential adverse effects is essential for healthcare professionals and students alike.

Spectrum of Activity

Voriconazole exhibits activity against a wide range of fungi, including:

  • Aspergillus spp. – a common cause of invasive aspergillosis
  • Candida spp. – including non-albicans strains like Candida glabrata and Candida krusei
  • Cryptococcus neoformans
  • Scedosporium spp.
  • Fusarium spp.

Its broad activity makes it a valuable option in treating invasive fungal infections, especially when resistance or intolerance to other antifungals is present.

Dosing and Administration

The dosing of voriconazole varies based on the patient’s age, weight, and the severity of the infection. Typically, the medication is administered either orally or intravenously.

Adult Dosing

For most invasive fungal infections, the recommended initial dose is:

  • 6 mg/kg IV every 12 hours for the first 24 hours
  • Followed by 4 mg/kg IV every 12 hours or 200 mg orally twice daily

The oral dose can be adjusted based on clinical response and drug levels, with a typical maintenance dose of 200 mg twice daily.

Pediatric Dosing

Pediatric dosing is weight-based, often starting with:

  • For children aged 2 years and older: 8 mg/kg IV every 12 hours for the first 24 hours, then 4 mg/kg IV every 12 hours
  • Orally, 200 mg twice daily, with adjustments as needed

Monitoring drug levels is recommended to ensure efficacy and minimize toxicity.

Adverse Effects

While voriconazole is generally well-tolerated, it can cause various adverse effects, some of which require monitoring and management.

Common Adverse Effects

  • Visual disturbances: blurred vision, altered color perception
  • Hepatotoxicity: elevated liver enzymes, hepatitis
  • Gastrointestinal symptoms: nausea, vomiting, diarrhea

Serious Adverse Effects

  • QT prolongation: risk of cardiac arrhythmias
  • Skin reactions: rash, photosensitivity, Stevens-Johnson syndrome
  • Neurotoxicity: hallucinations, confusion

Patients on voriconazole should be monitored regularly for liver function, cardiac health, and visual changes. Dose adjustments or discontinuation may be necessary if adverse effects occur.

Conclusion

Voriconazole is a potent antifungal with a broad spectrum of activity, making it a critical tool in managing invasive fungal infections. Proper dosing, vigilant monitoring for adverse effects, and understanding its spectrum are essential for optimal patient outcomes. Continued research and clinical experience will further refine its use in various patient populations.